Number of Risky Lifestyle Behaviors and Breast Cancer Risk

JNCI Cancer Spectrum
Merete Ellingjord-DaleGiske Ursin

Abstract

Lifestyle factors are associated with overall breast cancer risk, but less is known about their associations, alone or jointly, with risk of specific breast cancer subtypes. We conducted a case-control subjects study nested within a cohort of women who participated in the Norwegian Breast Cancer Screening Program during 2006-2014 to examine associations between risky lifestyle factors and breast cancer risk. In all, 4402 breast cancer cases subjects with information on risk factors and hormone receptor status were identified. Conditional logistic regression was used to estimate odds ratios (ORs), with 95% confidence intervals (CIs), in relation to five risky lifestyle factors: body mass index (BMI) of 25 kg/m² or greater, three or more glasses of alcoholic beverages per week, ever smoking, fewer than four hours of physical activity per week, and ever use of menopausal hormone therapy. Analyses were adjusted for education, age at menarche, number of pregnancies, and menopausal status. All statistical tests were two-sided. Compared with women with no risky lifestyle behaviors, those with five had 85% (OR = 1.85, 95% CI = 1.42 to 2.42, Ptrend < .0001) increased risk of breast cancer overall. This association was limited to luminal...Continue Reading

References

Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M C HungR A Weinberg
May 5, 1993·Journal of the National Cancer Institute·M E ReichmanP R Taylor
Feb 10, 1998·International Journal of Cancer. Journal International Du Cancer·A MorabiaB Borisch
Feb 28, 1998·JAMA : the Journal of the American Medical Association·S A Smith-WarnerD J Hunter
Feb 17, 2000·Journal of the National Cancer Institute·R K RossM C Pike
Jul 7, 2000·The New England Journal of Medicine·M J StampferW C Willett
May 3, 2001·Journal of the National Cancer Institute·J F DorganP R Taylor
Aug 5, 2003·The Oncologist·Jeffrey S RossKenneth J Bloom
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Jul 13, 2006·Archives of Internal Medicine·Tobias KurthJulie E Buring
Jun 28, 2007·European Journal of Epidemiology·Solveig HofvindPer Skaane
Dec 11, 2007·International Journal of Cancer. Journal International Du Cancer·Reiko SuzukiAlicja Wolk
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Inger Kristin LarsenBjørn Møller
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Kåre EdvardsenEiliv Lund
Oct 13, 2010·American Journal of Epidemiology·Deborah A BoggsLynn Rosenberg
Oct 21, 2010·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Dec 16, 2010·British Journal of Cancer·L BagliettoG G Giles
Jan 26, 2011·Archives of Internal Medicine·Fei XueKarin B Michels
Feb 22, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Luisa María Sánchez-ZamoranoGabriela Torres-Mejía
Mar 2, 2013·Journal of the National Cancer Institute·Mia M GaudetMichael J Thun
Jun 20, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Theresa A HastertEmily White
Aug 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Oct 3, 2013·Cancer Causes & Control : CCC·Lynn RosenbergJulie R Palmer
Feb 1, 2014·World Journal of Surgery·Se Kyung LeeSeok Jin Nam
Feb 28, 2014·Cancer Prevention Research·Laureen DartoisFrançoise Clavel-Chapelon
Mar 5, 2014·International Journal of Cancer. Journal International Du Cancer·Laure DossusFrançoise Clavel-Chapelon
Mar 20, 2014·British Journal of Cancer·S J NyanteL A Brinton
Jul 30, 2014·Climacteric : the Journal of the International Menopause Society·X Ruan, A O Mueck
Oct 5, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kelly A HirkoA Heather Eliassen
Nov 8, 2014·International Journal of Cancer. Journal International Du Cancer·Fiona McKenzieIsabelle Romieu

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Merete Ellingjord-DaleGiske Ursin
© 2021 Meta ULC. All rights reserved